(19)
(11) EP 4 680 637 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24710775.8

(22) Date of filing: 15.03.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/00(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2803; C07K 2317/76; C07K 2317/34; C07K 2317/35; A61K 39/3955; C07K 2317/24; C07K 2317/55; C07K 2317/92; A61K 2039/505
(86) International application number:
PCT/EP2024/056985
(87) International publication number:
WO 2024/189203 (19.09.2024 Gazette 2024/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 16.03.2023 EP 23162489

(71) Applicant: Emfret Analytics GmbH & Co. KG
97246 Eibelstadt (DE)

(72) Inventor:
  • NIESWANDT, Bernhard
    97246 Eibelstadt (DE)

(74) Representative: Kraus & Lederer PartGmbB 
Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)

   


(54) ANTI-GPVI ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF